Ellen Kullman - raising
DuPont's biotech game
“Bio-based technologies are an evolution, not a revolution,” Ellen said. “Modern uses of biotechnology, including industrial biotechnology, are just starting and there are vast opportunities to use these tools in new and valuable ways.”
Kullman was serving as a WEF annual meeting co-chair and participated in a forum panel on delivering bio-driven development”. This discussed how bio-based technologies can change the future of development in rural areas.
DuPont is staking a lot on the Danisco purchase but is following the strategy of addressing mega-trends on which this blog has already shed some light. Acquisition is one way to accelerate the move into new technology areas for DuPont. But as with all M&A deals, post-merger delivery is the critical step.
But as Nigel Davis, Insight editor at ICIS, commented recently: "The bid, welcomed as a good fit – and a good price – by Danisco management, puts DuPont in an extremely strong position as it strives to develop the enzymes that will create second-generation biofuels as well as other bio-based products."